PMEPA1 and renal carcinoma: TMEPAI is a TGFβ-induced protein that is known to convert TGFβ from a tumor suppressor into a tumor promoter in breast cancer, and is associated with increased migration in prostate and renal carcinomas [18], [40], [41].